Merete Lund Hetland
University of Copenhagen
Publications 377
Published on Sep 10, 2019in Arthritis Care and Research4.53
T. Thomsen7
Estimated H-index: 7
Mette Aadahl26
Estimated H-index: 26
(UCPH: University of Copenhagen)
+ 8 AuthorsPoul Jennum39
Estimated H-index: 39
(UCPH: University of Copenhagen)
Published on Mar 14, 2019in Current Medical Research and Opinion2.35
Jeffrey R. Curtis59
Estimated H-index: 59
(UAB: University of Alabama at Birmingham),
Ch Brahe1
Estimated H-index: 1
(UCPH: University of Copenhagen)
+ 7 AuthorsTom W. J. Huizinga91
Estimated H-index: 91
(LUMC: Leiden University Medical Center)
AbstractObjective. To compare the multi-biomarker disease activity (MBDA) score with the DAS28-CRP and CRP for predicting risk of radiographic progression in patients with rheumatoid arthritis.Methods. Published studies of the MBDA score and radiographic progression with ≥100 patients per cohort were evaluated. Rates of radiographic progression over 1 year were determined across the low/moderate/high categories for MBDA score (low/moderate/high: 44), DAS28-CRP (low/moderate/high: ≤2.67, >2.67–4....
Published on Feb 15, 2019in The Journal of Rheumatology3.63
Ulf Sundin (University of Oslo), Mikkel Østergaard66
Estimated H-index: 66
(UCPH: University of Copenhagen)
+ 10 AuthorsPaul Bird28
Estimated H-index: 28
(UNSW: University of New South Wales)
Objective The RAMRIS [Outcome Measures in Rheumatology rheumatoid arthritis (RA) magnetic resonance imaging (MRI) Scoring system] is used in clinical RA trials. We have investigated methods to combine the RAMRIS features into valid and responsive scores for inflammation and joint damage. Methods We used data from 3 large randomized early RA trials to assess 5 methods to develop a combined score for inflammation based on RAMRIS bone marrow edema, synovitis, and tenosynovitis scores, and a combine...
Published on 2019in Annals of the Rheumatic Diseases14.30
Lykke Midtbøll Ørnbjerg7
Estimated H-index: 7
Cecilie Heegaard Brahe2
Estimated H-index: 2
+ 7 AuthorsMaria José Santos23
Estimated H-index: 23
Background The efficacy of Tumour Necrosis Factor Inhibitor (TNFi) in patients with axial spondyloarthritis (axSpA) has been investigated in randomized controlled trials (RCTs) with strict inclusion and exclusion criteria. Patients treated in routine care are more heterogeneous and only ≈20-30% of patients receiving TNFi in routine care would have been eligible to be enrolled in the RCTs1. This emphasizes the need for real-world observational data as a valuable supplement to RCTs. Studying large...
Published on Jul 3, 2019in Arthritis & Rheumatism9.00
Kathrine Lederballe Grøn2
Estimated H-index: 2
(UCPH: University of Copenhagen),
Bente Glintborg13
Estimated H-index: 13
(UCPH: University of Copenhagen)
+ 6 AuthorsMerete Lund Hetland43
Estimated H-index: 43
(UCPH: University of Copenhagen)
Published on Jun 29, 2019in Arthritis Care and Research4.53
Jette Primdahl7
Estimated H-index: 7
(University of Southern Denmark),
Dorte Vendelbo Jensen18
Estimated H-index: 18
+ 7 AuthorsBente Appel Esbensen11
Estimated H-index: 11
(UCPH: University of Copenhagen)